Virus Diseases Completed Phase 3 Trials for Rotavirus Vaccine (DB10276)

Also known as: Virus Disease

IndicationStatusPhase
DBCOND0028162 (Virus Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01341639Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)Prevention
NCT01340937A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)Prevention
NCT01337167Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)Prevention
NCT01839175Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster VaccinationPrevention